Collectively, these data demonstrate the synergistic anti-tumor effects of pharmacological WEE1 and CHK1 inhibition and highlight the potential of this unique combination in treating human cancer independently of chemotherapeutic drugs. Here, WEE1 is linked to neoplasm.